Lava Therapeutics N.V. (LVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LVTX | INMB | RNXT | ||
| Company | Lava Therapeutics N.V. | Inmune Bio Inc | Renovorx Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.8100 | 1.7700 | 0.9653 | ||
| High | 1.8200 | 1.8697 | 1.0999 | ||
| Low | 1.6200 | 1.7200 | 0.9500 | ||
| Last | 1.7400 | 1.8500 | 1.0600 | ||
| Change | -0.0700 | +0.1000 | +0.1017 | ||
| Percent Change | -3.87% | +5.71% | +10.61% | ||
| Volume | 285,500 | 222,800 | 703,800 | ||
| 20-Day Average Volume | 131,750 | 642,095 | 221,955 | ||
| Previous | 1.8100 | 1.7500 | 0.9583 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.6475 | 1.8375 | 0.9062 | ||
| 20-Day Raw Stochastic | 65.31% | 49.60% | 85.22% | ||
| 20-Day Relative Strength | 61.37 | 56.34 | 62.68 | ||
| Weighted Alpha | +38.19 | -14.55 | -9.76 | ||
| Today's Opinion | 100% Buy | 88% Buy | 8% Sell | ||
| Yesterday's Opinion | 100% Buy | 72% Buy | 8% Sell | ||
| Last Month's Opinion | 96% Buy | 24% Buy | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.35% since 11/13/25 | +6.94% since 07/27/26 | +9.83% since 07/27/26 | ||
| Low | 1.6000 on 11/17/25 | 1.6600 on 07/28/26 | 0.8800 on 07/28/26 | ||
| High | 1.8250 on 11/18/25 | 1.8697 on 08/03/26 | 1.0999 on 08/03/26 | ||
| 1-Month | |||||
| %Chg | +16.78% since 10/20/25 | +8.82% since 07/02/26 | +15.20% since 07/02/26 | ||
| Low | 1.4500 on 10/22/25 | 1.5400 on 07/07/26 | 0.8300 on 07/14/26 | ||
| High | 1.8250 on 11/18/25 | 2.1650 on 07/15/26 | 1.0999 on 08/03/26 | ||
| 3-Month | |||||
| %Chg | +14.10% since 08/20/25 | +22.52% since 05/01/26 | +20.00% since 05/01/26 | ||
| Low | 1.4000 on 09/19/25 | 1.2000 on 06/11/26 | 0.7700 on 05/19/26 | ||
| High | 1.8250 on 11/18/25 | 2.1650 on 07/15/26 | 1.0999 on 08/03/26 | ||
| 6-Month | |||||
| %Chg | +31.82% since 05/20/25 | +19.35% since 02/03/26 | +4.95% since 02/03/26 | ||
| Low | 1.1800 on 05/30/25 | 1.0900 on 03/31/26 | 0.7700 on 05/19/26 | ||
| High | 1.8250 on 11/18/25 | 2.1650 on 07/15/26 | 1.3000 on 03/26/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 45,771 | 46,524 | 43,174 | ||
| Shares Outstanding, K | 26,305 | 26,585 | 45,053 | ||
| Annual Sales, $M | 11,980,000 | 50,000 | 1,120,000 | ||
| Annual Net Income, $M | -25,110,000 | -45,930,000 | -11,170,000 | ||
| Last Qtr Sales, $M | 0 | 0 | 560,000 | ||
| Last Qtr Income, $M | -7,190,000 | -5,410,000 | -3,520,000 | ||
| 60-Month Beta | 0.50 | 0.97 | 0.99 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.27 on 11/06/25 | -0.20 on 05/07/26 | -0.08 on 05/14/26 | ||
| Latest Earnings Date | 03/27/26 | 08/06/26 | 08/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||